217 related articles for article (PubMed ID: 30558727)
1. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology.
Ren B; Liu X; Suriawinata AA
Am J Pathol; 2019 Jan; 189(1):9-21. PubMed ID: 30558727
[TBL] [Abstract][Full Text] [Related]
2. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
World J Gastroenterol; 2014 Oct; 20(38):13833-41. PubMed ID: 25320520
[TBL] [Abstract][Full Text] [Related]
3. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
Singh M; Maitra A
Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of pancreatic cancer.
Hong SM; Park JY; Hruban RH; Goggins M
Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
[TBL] [Abstract][Full Text] [Related]
5. Pathology of Pancreatic Cancer Precursor Lesions.
Noë M; Brosens LA
Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
[TBL] [Abstract][Full Text] [Related]
6. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
7. Precursors of pancreatic cancer.
Frič P; Škrha J; Šedo A; Bušek P; Laclav M; Bunganič B; Zavoral M
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):e13-e18. PubMed ID: 28009716
[TBL] [Abstract][Full Text] [Related]
8. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas.
Pittman ME; Rao R; Hruban RH
Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063
[TBL] [Abstract][Full Text] [Related]
9. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
Scarlett CJ; Salisbury EL; Biankin AV; Kench J
Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
[TBL] [Abstract][Full Text] [Related]
10. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.
Kopp JL; von Figura G; Mayes E; Liu FF; Dubois CL; Morris JP; Pan FC; Akiyama H; Wright CV; Jensen K; Hebrok M; Sander M
Cancer Cell; 2012 Dec; 22(6):737-50. PubMed ID: 23201164
[TBL] [Abstract][Full Text] [Related]
11. Current topics on precursors to pancreatic cancer.
Takaori K; Hruban RH; Maitra A; Tanigawa N
Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272
[TBL] [Abstract][Full Text] [Related]
12. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
Distler M; Aust D; Weitz J; Pilarsky C; Grützmann R
Biomed Res Int; 2014; 2014():474905. PubMed ID: 24783207
[TBL] [Abstract][Full Text] [Related]
13. P53 expression in invasive pancreatic adenocarcinoma and precursor lesions.
Norfadzilah MY; Pailoor J; Retneswari M; Chinna K; Noor LM
Malays J Pathol; 2011 Dec; 33(2):89-94. PubMed ID: 22299208
[TBL] [Abstract][Full Text] [Related]
14. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs.
Hruban RH; Fukushima N
Mod Pathol; 2007 Feb; 20 Suppl 1():S61-70. PubMed ID: 17486053
[TBL] [Abstract][Full Text] [Related]
17. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
18. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression.
Kim J; Hoffman JP; Alpaugh RK; Rhim AD; Reichert M; Stanger BZ; Furth EE; Sepulveda AR; Yuan CX; Won KJ; Donahue G; Sands J; Gumbs AA; Zaret KS
Cell Rep; 2013 Jun; 3(6):2088-99. PubMed ID: 23791528
[TBL] [Abstract][Full Text] [Related]
19. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.
Siveke JT; Einwächter H; Sipos B; Lubeseder-Martellato C; Klöppel G; Schmid RM
Cancer Cell; 2007 Sep; 12(3):266-79. PubMed ID: 17785207
[TBL] [Abstract][Full Text] [Related]
20. [Pathology of pancreatic ductal adenocarcinoma].
Strausz T
Magy Onkol; 2021 Oct; 65(3):214-221. PubMed ID: 34614042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
